In 2023, North America emerged as the frontrunner in the market for fertility supplements, commanding a substantial 35.6% share of the global revenue. The region's dominance is attributed to a surge in infertility rates and heightened public awareness regarding overall health, driving significant growth prospects for North America over the forecast period.
https://www.maximizemarket...